Research has also demonstrated that targeting specific pathways, such as inhibiting Stearoyl CoA desaturase (SCD) or modulating the complement system, can restore cognitive functions and reduce AD pathology [85,89]. The gene discussed is SCD; the disease is Alzheimer disease.